Table 2

Costs for screening for ROP among preterm infants (in 2020 values)

#First author (year)Screening costsTreatment costsEvidence ratingCost inclusion
Mean per examMean per infantMean per infant
(US$)(US$)(US$)
1Mohammadi (2021)1411694Charges
2Moitry (2018)15443Direct cost
3Isaac (2018)16HSN: 342
RVH: 371
3Direct cost not including equipment
4Kelkar (2017a)1725365004Direct cost including equipment and labour
5Kelkar (2017b)1821041374Direct cost including equipment and labour
6Rothschild (2016)19US: 1072
Mexico: 362
US: 4413
Mexico: 552
4Direct cost including equipment and labour
7van der Akker-van Merle (2015)201604064*3Direct cost
8Wongwai (2015)215382Charges including equipment and labour
9Black (2015)223
10Zin (2014)23204505Direct cost including equipment and labour
11Dave (2012)243
12Dunbar (2009)2511940517593Charges
13Kamholz (2009)262505661*5Charges
14Jackson (2008)272051Charges
15Yanowitch (2006)2832428143Charges
16Castillo-Riquelme (2004)29106602Unilateral: 1165 Bilateral: 15145Direct cost including equipment and maintenance
17Lee (2001)30Unilateral: 11225073Direct cost
18Brown (1999)3125271Charges
19Javitt (1993)32First: 183
Follow-up: 149
3Charges
  • Evidence rating indicates the quality of evidence rating of included studies: 1=for example, properly powered randomised controlled trials; 2=for example, prospective cohort studies; 3=for example, retrospective cohort studies; 4=case series with or without intervention or cross-sectional study; 5=for example, opinion of respected authorities.

  • *Unit cost per treatment.

  • HSN, Health Sciences North in Sudbury; ROP, etinopathy of prematurity; RVH, Royal Victoria Hospital in Barrie.